Diagnostic Significance of Nitrates and Nitrites and L-Arginine, in Development of Hepatorenal Syndrome in Patients with End Stage Alcoholic Liver Cirrhosis

REFERENCES

• Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet. 2003;362:1819–1827.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gine’s P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318.
   PubMed Web of Science ®Google Scholar
• Alderton W, Cooper C, Knowles R. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357: 593–615.
   PubMed Web of Science ®Google Scholar
• Gow AJ, Luchsinger BP, Pawlovski JR, Singel DJ, Stampler JS. The oxihemoglobin reaction of nitric oxide. Proc Natl Acad Sci ASA. 1999;96:9027–9032.
   PubMed Web of Science ®Google Scholar
• Kim M, Talanian V, Billiar R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem. 1997;272:31138–31148.
   PubMed Web of Science ®Google Scholar
• Feletou M, Vanhoutte M. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol. 2006;291:H985– 1002.
   PubMed Web of Science ®Google Scholar
• Taylor BS, Alarcon L, Billiar TR. Inducible Nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc). 1998;63(7):766–781.
   PubMed Web of Science ®Google Scholar
• Joshi S, Ferguson B, Han H, et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci USA. 2002;6:10341–10346.
   Google Scholar
• Shah V, Haddad G, Garcia-Cardena G, et al Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest. 1997;100:2923–2930.
   PubMed Web of Science ®Google Scholar
• Farzaneh-Far R, Moore K. Nitric oxide and the liver. Liver. 2001;21:161–174.
   PubMedGoogle Scholar
• Gines P, Renal SD. Failure in Cirrhosis. Review article N Engl J Med. 2009;361:1279–1290.
   PubMed Web of Science ®Google Scholar
• Genesca J, Gonzalez A, Segura R, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol.1999;94:169–177.
   PubMed Web of Science ®Google Scholar
• Nickovic V, Nikolic J, Djindjić N, et al. Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis. Vojnosan Pregled. 2012;69:686–691.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gine’s P, Wong F, Arroyo V. Diagnosis prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318.
   PubMed Web of Science ®Google Scholar
• Navarro-Gonzales JA, Garcia-Benayas C, Arenos J. Semiautomated measurement of nitrate in biological fluids. Clin Chem. 1998;44:679–682.
   PubMed Web of Science ®Google Scholar
• Arkenau T, Stichtenoth O, Frolich C, Manns P, Boker H. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol. 2002;40:907–913.
   PubMed Web of Science ®Google Scholar
• Feletou M, Vanhoutte M. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol. 2006;291:H985–1002.
   PubMed Web of Science ®Google Scholar
• Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297–306.
   PubMed Web of Science ®Google Scholar
• Friedman L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247–2250.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum I. Alcohol oxidative stress, and free radical damage. Alcohol Res Health. 2003;27:277–284.
   PubMedGoogle Scholar
• Parvu1 A, Negrean V, Pleca-Manea1 L, Cosma A, Draghici A. Nitric oxide in patients with chronic liver diseases. Romanian J Gastroenterol. 2005;14:225–230.
   PubMedGoogle Scholar
• Capone F, Guerriero E, Sorice A, et al. Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients. Clin Biochem. 2012;45:525–529.
   PubMed Web of Science ®Google Scholar
• Mohammed N, El-Aleem S, Appleton I, et al Expression of nitric oxide synthase isoforms in human liver cirrhosis. Patology. 2003;200:647–655.
   Google Scholar
• Kirkham P. Oxidative stress and macrophage function: a failure to resolve the inflammatory response. Biochem Soc Trans. 2007;35:284–287.
   PubMed Web of Science ®Google Scholar
• Kirkali G, Gezer S, Umur N, Ali M, Tankurt Z. Nitric oxide in chronic liver disease. Turk J Med Sci. 2000;30:511–515.
   Google Scholar
• Higashino H, Tabuchi M, Yamagata S, et al. Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects. J Med Sci. 2010;10:1–11.
   Google Scholar
• Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911.
   PubMed Web of Science ®Google Scholar
• Turkay C, Yonem O, Arikan O, Baskin E. Nitric oxide and renal functions in liver cirrhosis. Turk J Gastroenterol. 2004;15:73–76.
   PubMedGoogle Scholar
• Porst M, Hartner A, Krause H, Hilgers KF, Veelken R. Inducible nitric oxide synthase and glomerular hemodynamics in rats with liver cirrhosis. Am J Physiol Renal Physiol. 2001;281:F293–F299.
   Web of Science ®Google Scholar
• Granata S, Zaza G, Simone S, et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.BMC Genomics. 2009;10:388.
   PubMed Web of Science ®Google Scholar
• Martin Y, Gin SP, Schrier W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Eng J Med. 1998;339:533–541.
   PubMed Web of Science ®Google Scholar
• Albillos A, Rossi I, Cacha G, et al. Enhanced endothelium-dependent vasodilatation in patients with cirrhosis. Am J Physiol. 1995;268:G459–G464.
   PubMedGoogle Scholar
• Guarner C, Soriano G, Tomas A, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;18:1139–1143.
   PubMed Web of Science ®Google Scholar
• Dickhout JG, Hossain GS, Pozza LM, Zhou J, Lhotak S, Austin RC. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:2623–2629.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Argiles A, Baurmeister U, et al. Uremic toxicity: present state of the art. Int J Artif Organs. 2001;24:695–725.
   PubMed Web of Science ®Google Scholar
• Cherla G, Jaimes EA. Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr. 2004;134:2801S-6.
   Web of Science ®Google Scholar